Sandoz Biopharmaceuticals
Sandoz , a Novartis division , is the pioneer in biosimilars
Our biosimilars have been used in clinical practice for over 10 years , are available in over 86 countries and have over 450 million patient-days of experience
HQ / BIO / 18-0032
References : 1 . Schubert-Tennigkeit , A ., & Kothare , S . Zarzio ® ( Filgrastim ) PSUR 16 Sep 2017 to 15 Mar 2018 . 2 . Zeldin , G ., et al . Rituximab ® ( GP2013 ) PSUR 15 Jun 2017- 17 Nov 2017 . 3 . Zeldin , G ., et al . Omnitrope ® ( Somatropin ) PSUR 01 Oct 2017 to 31 Mar 2018 . 4 . Tolksdorf , J ., et al . Etanercept ( GP2015 ) PSUR P1 ( 23 Jun 2017 to 14 Jan 2018 ) 5 . Zeldin , G ., & Kamble , K . Binocrit ( Erythropoietin / epoetin alfa ) PSUR 01 Sep 2017 to 28 Feb 2018 .